As Republican legislatures pass bills limiting reproductive rights, women are being forced to travel farther from home to obtain the care they need.
The FDA writes that failure to immediately cease sales of unapproved versions of mifepristone and misoprostol may result in action.
Mainstream M4A proposals just got a lot more inclusive.